發送短信 : Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 _    _     ______    _____      ___     _    _   
| || | ||  /_   _//  / ____||   / _ \\  | \  / || 
| || | ||   -| ||-  / //---`'  / //\ \\ |  \/  || 
| \\_/ ||   _| ||_  \ \\___   |  ___  ||| .  . || 
 \____//   /_____//  \_____|| |_||  |_|||_|\/|_|| 
  `---`    `-----`    `----`  `-`   `-` `-`  `-`